Brazil Medical Devices Market Size, Share & Industry Analysis, By Type (Orthopedic Devices, Cardiovascular Devices, Diagnostic Imaging, In-vitro Diagnostic (IVD), Minimally Invasive Surgery Devices (MIS), Wound Management, Diabetes Care Devices, Ophthalmic Devices, Dental Devices, Nephrology Devices, General Surgery, and Others), By End-user (Hospitals & ASCs, Clinics, and Others), and Country Forecast, 2025-2032

The Brazil medical devices market size was valued at USD 15.28 billion in 2024. The market is projected to grow from USD 16.15 billion in 2025 to USD 25.00 billion by 2032, exhibiting a CAGR of 6.4% during the forecast period.

Medical devices are tools designed to prevent, diagnose, or treat illness or disease, and to restore, correct, or modify body functions or structures. They are used for both internal and external applications. Some of these devices include thermometers, blood glucose meters, pacemakers, prosthetics, wearable sensors, scalpels, sutures, reagents, test kits, and more.

The market growth is attributed to the increasing prevalence of chronic conditions such as coronary artery blockage, tumors, diabetic foot ulcers, and others. These conditions are driving the need for surgical intervention, thereby spurring the utilization of medical devices. As a result, market players are increasing their product supply to healthcare settings, thereby increasing product penetration.

Some of the key players operating in the Brazil market are Medtronic, Johnson & Johnson Services, Inc., GE Healthcare, and Cardinal Health. These players are involved in strategic alliances and new product launches, which are expected to help them gain market share.

MARKET DYNAMICS

Market Drivers

Increasing Prevalence of Chronic Diseases to Fuel Market Growth

Over the past few years, there has been a surge in the prevalence of chronic diseases, such as cardiovascular disorders, cancer, diabetes, and respiratory conditions, that are driving the need for diagnosis and surgical intervention to overcome complications associated with these diseases. This, in turn, is propelling the demand for diagnostic, monitoring, and therapeutic devices across Brazil.

For instance, according to the data published by the International Diabetes Federation, around 16,621,400 adults had diabetes in Brazil in 2024. Such a higher prevalence of diabetes is driving the demand for continuous glucose monitoring systems, blood glucose monitors, insulin pens, safety lancets, and others. Similarly, increasing cases of cardiovascular diseases are spurring the demand for pacemakers, heart rate monitors, ECG machines, and coronary stents in both healthcare and home care settings.

Moreover, the increasing geriatric population in Brazil is also increasing the susceptibility to these conditions, thereby fueling the usage of medical devices. Additionally, the government's strategic initiatives, such as Universal Healthcare Coverage (SUS), to improve healthcare access, are expanding the reach of innovative medical devices to underserved areas, which is anticipated to drive the Brazil medical devices market growth in the forthcoming years.

Market Restraints

Product Recalls to Hamper the Market Growth

Although the increasing adoption of advanced medical instruments has increased the number of product launches, the product recalls due to functional and safety issues are hampering their demand, as healthcare systems are prioritizing patient safety. As a result, the medical devices posing health risks due to defects are resulting in product recalls by regulatory authorities.

• For instance, in July 2025, the National Health Surveillance Agency (ANVISA) ordered the recall and suspended Biomolecular Technology Trade, Export and Distribution of Medical and Laboratory Materials Ltd.’s OKPR000266508, OKPR000266498, and OKPR000266509 batches of blood glucose meter product OK PRO FAMILY as these batches failed reproducibility test, conformity analysis, labeling analysis, and repeatability test.

Such product recalls are raising concerns among both healthcare providers and patients, thereby decreasing confidence to adopt this type of device in monitoring, diagnosis, and treatment, which is expected to hinder the market growth during the forecast period.

Market Opportunities

3D Printing to Serve as a Transformative Opportunity for Market Growth

In recent years, there has been a growing adoption of 3D printing of medical devices in Brazil. This technology is effectively addressing challenges related to customization, costs, and manufacturing.

In the underserved areas of the country, 3D printing is enhancing the manufacturing processes and helping in the fabrication of prosthetics, dental implants, and orthopedic devices. This is expected to present a lucrative opportunity for the 3D printing solution providers and medical device manufacturers, enhancing the scenario of customized devices.

• For instance, in August 2019, Materialise, the provider of 3D printing solutions, invested in Engimplan, a Brazilian manufacturer of orthopedic and cranio-maxillofacial (CMF) implants, to boost the introduction of 3D printed, personalized implants and instruments.

Moreover, 3D printing has shortened the time of manufacturing. As a result, several players, including foreign companies and healthcare facilities in Brazil, are preferring 3D printing solutions for fabricating customized devices. Such a scenario is creating investment opportunities for 3D printing solution providers to expand in the Brazil market.

Market Challenges

High Cost of Advanced Medical Devices to Hamper the Market Growth

Despite the advancement in medical technologies and the increasing number of surgical and diagnostic procedures,  high cost of advanced equipment remains a major challenge for its adoption, especially among smaller clinics in Brazil. Investing in the next-generation surgical systems, imaging devices, and AI-based tools is a major challenge for these settings due to comparatively fewer patient visits than multi-specialty hospitals.

• For instance, according to the article published by ScienceDirect in 2022, the da Vinci surgical system price was around USD 1.7 million (BRL 9.5 million) in Brazil.

Additionally, the maintenance of these devices, training of staff, importing accessories, and registration processes are increasing the overall costs for healthcare facilities. This is limiting the adoption of technologically advanced and high-quality medical devices among small healthcare facilities, which is expected to pose a major challenge in market expansion during the forecast period.

Brazil Medical Devices Market Trends

Increasing Preference For Minimally Invasive Surgeries Is A Key Market Trend

In recent years, there has been a shift towards minimally invasive procedures among patients and healthcare providers in Brazil. This is increasing the demand for endoscopic devices, laparoscopic instruments, and robotic surgical systems.

• For instance, according to the article published by the NCBI as of September 2023, nearly 118,000 robotic-assisted surgical procedures were performed in Brazil.

Minimally invasive surgeries (MIS) offer benefits such as shorter recovery times, reduced hospital stays, and minimal blood loss during procedures, which is increasing their preference among Brazil’s population. Additionally, the adoption of these procedures is high among the aging population and individuals more prone to chronic conditions such as hernia, cardiovascular issues, and gallbladder problems due to the lower complication rates associated with MIS.

These surgeries are helping hospitals increase surgical volume and reduce the burden on post-operative care units. As a result, hospitals in Brazil are increasingly investing in advanced surgical systems, which are expected to reshape the surgical scenario of the country.

Download Free sample to learn more about this report.

Segmentation Analysis

By Type

In-vitro Diagnostics (IVD) Segment Dominated the Market Due to Increasing Demand for Disease Screening, Monitoring, and Diagnosis

Based on type, the market is segmented into orthopedic devices, cardiovascular devices, diagnostic imaging, in-vitro diagnostic (IVD), minimally invasive surgery devices (MIS), wound management, diabetes care devices, ophthalmic devices, dental devices, nephrology devices, general surgery, and others.

The in-vitro diagnostic (IVD) dominated the market in 2024. This share is attributed to the increasing focus on Brazil’s public and private healthcare facilities toward infections and chronic disease detection, monitoring, and diagnosis. As a result, there is an increasing availability of over-the-counter IVD tests and related devices in the country, which is expected to increase the product penetration.

The diagnostic imaging segment held the third-largest Brazil medical devices market share in 2024. The growth is attributed to the higher penetration of diagnostic imaging devices such as X-ray, CT scanners, MRI machines, and others. This penetration is supported by the increasing healthcare infrastructure and healthcare spending over the past few years in the country.

• For instance, according to the data published by the UMass Chan Medical School, there were 6,219 CT scanners, 19,095 conventional ultrasonography units, and 3,174 MRI machines in Brazil as of 2022.

To know how our report can help streamline your business, Speak to Analyst

By End-user

Hospitals & ASCs Dominated Due to Large Number of Private Hospitals

Based on end-user, the market is segmented into hospitals & ASCs, clinics, and others.

The hospitals & ASCs segment held a dominating share in 2024. This growth is attributed to a large number of private hospitals in Brazil, which are well-equipped and contribute to a significant number of diagnostic and surgical procedures in the country. Such a scenario is driving the utilization of advanced medical devices in these settings.

• For instance, according to the data published by the International Trade Administration (ITA) in December 2023, there were 7,191 hospitals in Brazil, out of which 62.0% were privately owned.

The clinics segment held the second-largest share of the Brazil market in 2024. The growth is attributed to an increasing number of healthcare specialists, in turn leading to the launch of private clinics, especially in urban areas. This is expected to drive the need for advanced imaging and surgical equipment in these settings.  

COMPETITIVE LANDSCAPE

Key Market Players

Medtronic, Johnson & Johnson Services, Inc., GE Healthcare, and Cardinal Healthcare to Dominate Due to Strong Focus on Commercialization

The Brazil market is fragmented, with companies such as Medtronic, Johnson & Johnson Services, Inc., GE Healthcare, and Cardinal Healthcare holding a substantial share in 2024. This share is attributed to higher investment by these players towards commercializing advanced medical equipment in Brazil.

Other major players such as Abbott, Koninklijke Philips N.V., Siemens Healthineers AG, and BD are focusing on collaborations, acquisitions, and new product launches to expand their footprint in the market. These initiatives are set to help them capitalize the market with a substantial share during the forecast timeframe.

LIST OF KEY BRAZIL MEDICAL DEVICES COMPANIES PROFILED

• Medtronic (Ireland)
• Johnson & Johnson Services, Inc. (U.S.)
• Koninklijke Philips N.V (Netherlands)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Boston Scientific Corporation (U.S.)
• Fresenius Medical Care AG (Germany)
• GE Healthcare (U.S.)
• Siemens Healthineers AG (Germany)
• Stryker (U.S.)
• Abbott (U.S.)
• BD (U.S.)
• Cardinal Health (U.S.)

KEY INDUSTRY DEVELOPMENTS

• March 2025 – Olympus Corporation launched the EVIS X1 endoscopy system in Brazil to improve outcomes from stomach, colon, and oesophagus disorders.
• March 2025 – Med Systems, Inc. acquired Vydence Medical, a Brazilian manufacturer of medical aesthetics equipment, to expand its business in the country’s dermatology sector.
• October 2023 – Boston Scientific Corporation announced its plan to establish its first Brazil-based manufacturing site in Shanghai, expanding its footprint in Brazil.
• November 2021 – Neoteryx’s microsampling device got registered as a Class 1 in vitro diagnostic (IVD) medical device by ANVISA in Brazil.
• November 2020 – Samsung NeuroLogica announced the installation of a NeuroLogica Mobile Stroke CT scanner at the Santa Lúcia Hospital Network in Brasilia, Brazil.

REPORT COVERAGE

The market report provides a detailed analysis of key factors driving the market growth, including trends, drivers, and opportunities. The report provides detailed information on the competitive landscape, leading companies, and company profiles of the key players. It also highlights new launches, technological advancements, regulatory and reimbursement scenarios, and key industry developments.

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation